Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3...

A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their performance in simple...

Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...

On track to report data from the ongoing MYTHIC dose expansion clinical trial at the recommended Phase 2 dose (RP2D) at a company event in December...

Cutting off cancer cells’ access to fat may help a specific type of cancer treatment work more effectively, according to a study by Van Andel...

Discover how FarrSight (Regd) (Regd) -Twin technology utilizes digital twins to revolutionize cancer clinical trials by simulating patient...

A joint research team led by Professor Hyun-Woong Cho (Department of Obstetrics and Gynecology) and Professor Hyun Koo Kim (Department of Thoracic and...

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...

Research has shown that eating a plant-based diet may provide a healthier alternative to the standard American diet, which is typically high calorie,...